Alliance A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Objective

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

https://clinicaltrials.gov/ct2/show/NCT02194738

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Studies

Specialty

• Lung Cancer

Contact

Cancer Clinical Trials at 218-786-3308
or cancertrials@essentiahealth.org